125I粒子组织间植入治疗局部晚期胰腺癌进展
Advances in the therapy of pancreatic carcinoma with 125I seeds
-
摘要: 早在20世纪初人们就开始将放射性粒子用于胰腺癌治疗,但由于使用的放射性粒子如226Ra针、198Au、192Ir和222Rn等放射生物学或放射物理学方面的局限性,植入技术和植入计划系统的不健全,使得粒子植入治疗胰腺癌发展缓慢。20世纪60年代末期随着125I粒子临床应用,放射性核素放射生物学及放射物理学特性的深入研究,三维治疗计划系统的飞速发展,术中超声技术的使用,使得粒子植入治疗胰腺癌再度回归。Abstract: Radioactive seeds have been used to treat pancreatic carcinoma in the early twenty cen-tries. Advances in the therapy of pancreatic carcinoma with radioactive seeds is slow because of the limitations of radiobiology and radiophysics, unsoundness of implantation technique and implantation plan system. As the radioactive seeds 125I have been used since the late 1960s and radiobiology and radiophysics of radionucide has been studied profoundly, fast development of three-dimensional treatment plan system, useness of ultrasonically guided percutaneous implantation therapy for pancreatic carcinoma with radioactive seeds rise again.